How hospice became big business. A new investigation in The New Yorker reveals an industry that at times puts profits before patients.
There are an estimated 200 million cases of malaria worldwide each year, and around 600,000 deaths. But the last 15 years represent a success story in the fight against the disease: Increased investment in treatment and prevention have cut the death rate nearly in half. Now, researchers warn that resistance to the primary drug used to treat malaria is spreading. A new study has detected a resistant strain in Myanmar near the Indian border, raising concerns that resistance could soon extend its hold to sub-Saharan Africa, where more than 90 percent of malaria deaths occur. Diane and her guests discuss new concerns about combating malaria worldwide.
- Dr. Lawrence Barat Senior technical advisor to the President's Malaria Initiative at USAID
- Jason Beaubien Global health and development correspondent for NPR
- Dr. Alan Magill Director of the Malaria Program at the Bill & Melinda Gates Foundation
- Laurie Garrett Senior fellow for global health at the Council on Foreign Relations
- Dr. William Moss Professor of epidemiology at the Johns Hopkins Bloomberg School of Public Health; co-director of the Southern Africa International Center of Excellence for Malaria Research
Most Recent Shows
Pulitzer Prize-winning biographer Jon Meacham on the evolution of Abraham Lincoln's moral principles and political leadership -- and what the era of Lincoln can teach us about the state of our democracy today.
What troubles at Twitter say about the state of social media -- and why one tech watcher argues this could transform the industry in positive ways.
Political analyst Norman Ornstein on control of Congress, the red wave that wasn't, and other lessons from the midterm elections.